Hans Skvara

Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides

Karl J. Aichberger, Matthias Mayerhofer, Maria‐Theresa Krauth et al. · Blood · 2004 · 251 citations · Full text

Limitations of Dermoscopy in the Recognition of Melanoma

Hans Skvara, Ligia Teban, Manfred Fiebiger et al. · Archives of Dermatology · 2005 · 192 citations

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis

Hans Skvara, Markus Dawid, Elise Kleyn et al. · Journal of Clinical Investigation · 2008 · 160 citations · Full text

Immunology, Pharmacotherapy, Dermatology +17

Topical Treatment of Basal Cell Carcinomas in Nevoid Basal Cell Carcinoma Syndrome with a Smoothened Inhibitor

Hans Skvara, Frank Kalthoff, Josef G. Meingassner et al. · Journal of Investigative Dermatology · 2011 · 148 citations · Full text

Neuro-oncology, Smoothened Inhibitor, Dermatology +6

Glucocorticosteroids Modify Langerhans Cells To Produce TGF-β and Expand Regulatory T Cells

Georg Stary, Irene Klein, Wolfgang Bauer et al. · The Journal of Immunology · 2010 · 83 citations